Hatemi, G. Et Al. 2019. Efficacy of apremilast for oral ulcers associated with active Behcet's syndrome over 64 weeks: results from a phase III study. SWISS MEDICAL WEEKLY .

Hatemi, G., Mahr, A., Takeno, M., Kim, D., Saadoun, D., DİRESKENELİ, R. H., ... Cheng, S.(2019). Efficacy of apremilast for oral ulcers associated with active Behcet's syndrome over 64 weeks: results from a phase III study. SWISS MEDICAL WEEKLY .

Hatemi, G. Et Al. "Efficacy of apremilast for oral ulcers associated with active Behcet's syndrome over 64 weeks: results from a phase III study," SWISS MEDICAL WEEKLY , 2019

Hatemi, G. Et Al. "Efficacy of apremilast for oral ulcers associated with active Behcet's syndrome over 64 weeks: results from a phase III study." SWISS MEDICAL WEEKLY , 2019

Hatemi, G. Et Al. (2019) . "Efficacy of apremilast for oral ulcers associated with active Behcet's syndrome over 64 weeks: results from a phase III study." SWISS MEDICAL WEEKLY .

@article{article, author={G. Hatemi Et Al. }, title={Efficacy of apremilast for oral ulcers associated with active Behcet's syndrome over 64 weeks: results from a phase III study}, journal={SWISS MEDICAL WEEKLY}, year=2019}